Clover Health Investments Corp. Hits New 52-Week High of $5.18

Clover Health Investments Corp., a small-cap player in the insurance industry, has reached a significant milestone by hitting a new 52-week high of USD 5.18 on June 11, 2026. This achievement marks a notable increase from its 52-week low of USD 1.58, reflecting a substantial upward trend in the stock's performance over the past year. In the context of broader market performance, Clover Health's stock has outperformed the S&P 500, showcasing a 22.78% increase over the same period. Despite being a loss-making entity, the company operates within a market cap of USD 971 million, indicating its position as a small-cap stock in the competitive insurance sector. Key financial metrics reveal a price-to-book ratio of 3.15, while the company currently does not offer a dividend yield. Additionally, Clover Health's return on equity stands at -27.71%, highlighting the challenges it faces in generating profits. As the stock continues to navigate the market, its recent high underscores a pivotal moment in its performance trajectory.